BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37957154)

  • 1. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model.
    Fang TZ; Sun Y; Pearce AC; Eleuteri S; Kemp M; Luckhurst CA; Williams R; Mills R; Almond S; Burzynski L; Márkus NM; Lelliott CJ; Karp NA; Adams DJ; Jackson SP; Zhao JF; Ganley IG; Thompson PW; Balmus G; Simon DK
    Nat Commun; 2023 Nov; 14(1):7295. PubMed ID: 37957154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.
    Bingol B; Tea JS; Phu L; Reichelt M; Bakalarski CE; Song Q; Foreman O; Kirkpatrick DS; Sheng M
    Nature; 2014 Jun; 510(7505):370-5. PubMed ID: 24896179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Deubiquitylation: USP30-Mediated Regulation of Mitochondrial Homeostasis.
    Hou J; Eldeeb M; Wang X
    Adv Exp Med Biol; 2017; 1038():133-148. PubMed ID: 29178074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons.
    Okarmus J; Agergaard JB; Stummann TC; Haukedal H; Ambjørn M; Freude KK; Fog K; Meyer M
    Cell Death Dis; 2024 Jan; 15(1):52. PubMed ID: 38225227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy.
    Tufi R; Clark EH; Hoshikawa T; Tsagkaraki C; Stanley J; Takeda K; Staddon JM; Briston T
    SLAS Discov; 2023 Apr; 28(3):73-87. PubMed ID: 36608804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation.
    Rusilowicz-Jones EV; Jardine J; Kallinos A; Pinto-Fernandez A; Guenther F; Giurrandino M; Barone FG; McCarron K; Burke CJ; Murad A; Martinez A; Marcassa E; Gersch M; Buckmelter AJ; Kayser-Bricker KJ; Lamoliatte F; Gajbhiye A; Davis S; Scott HC; Murphy E; England K; Mortiboys H; Komander D; Trost M; Kessler BM; Ioannidis S; Ahlijanian MK; Urbé S; Clague MJ
    Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32636217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of USP30 activates tissue-specific mitophagy.
    Luo H; Krigman J; Zhang R; Yang M; Sun N
    Acta Physiol (Oxf); 2021 Jul; 232(3):e13666. PubMed ID: 33890401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease.
    Park GH; Park JH; Chung KC
    BMB Rep; 2021 Dec; 54(12):592-600. PubMed ID: 34674795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond.
    Bingol B; Sheng M
    Free Radic Biol Med; 2016 Nov; 100():210-222. PubMed ID: 27094585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
    Miller S; Muqit MMK
    Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches.
    Tsefou E; Walker AS; Clark EH; Hicks AR; Luft C; Takeda K; Watanabe T; Ramazio B; Staddon JM; Briston T; Ketteler R
    Biochem J; 2021 Dec; 478(23):4099-4118. PubMed ID: 34704599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease.
    Abd Elghani F; Safory H; Hamza H; Savyon M; Farhoud M; Toren-Hershoviz M; Vitic Z; Ebanks K; Shani V; Bisharat S; Shaulov L; Brodski C; Song Z; Bandopadhyay R; Engelender S
    Aging Cell; 2022 Dec; 21(12):e13731. PubMed ID: 36307912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
    Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
    Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling.
    Ordureau A; Paulo JA; Zhang J; An H; Swatek KN; Cannon JR; Wan Q; Komander D; Harper JW
    Mol Cell; 2020 Mar; 77(5):1124-1142.e10. PubMed ID: 32142685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing the inhibitors of MMP-9 and SGLT-2 against ubiquitin specific protease 30 in Parkinson's disease: computational modelling studies.
    Alshehri MM; Danazumi AU; Alshammari MK; Bello RO; Alghazwni MK; Alshehri AM; Alshlali OM; Umar HI
    J Biomol Struct Dyn; 2024; 42(3):1307-1318. PubMed ID: 37139557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
    Chen L; Xie Z; Turkson S; Zhuang X
    J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolically induced intracellular pH changes activate mitophagy, autophagy, and cell protection in familial forms of Parkinson's disease.
    Komilova NR; Angelova PR; Berezhnov AV; Stelmashchuk OA; Mirkhodjaev UZ; Houlden H; Gourine AV; Esteras N; Abramov AY
    FEBS J; 2022 Feb; 289(3):699-711. PubMed ID: 34528385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.